The technology licensed by ChondroNest SA is designed for the in vivo reconstruction of the scaffold of the Extra Cellular Matrix – ECM – with mechanical and biocompatible properties based on the natural biopolymers of living tissues.
From our research into the field, we could not find any of the current technologies that has ever been able to address the minute reconstruction of living tissues’ scaffold in operation theatres without the use of transplantation or implantation of foreign solid pieces with rigid shape and composition.
ChondroNest™ is a paste which can be placed and shaped by the surgeon following the exact requirements of the patient and also rapidly solidifies in biocompatible conditions.
02.06.2020
MassChallenge Switzerland reveals the 2020 cohort (startupticker.ch)
25.07.2016
Tour de financement réussi pour Chondronest (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Website:
www.chondronest.com/
Headquarter:
Conthey
Foundation Date:
October 2015
Sectors: